RAZA SAIYED ATIQ 4

What Happened
Raza Saiyed Atiq, a director of Arteris, sold a total of 90,279 shares of Arteris common stock in open-market transactions between Feb 25–27, 2026, generating approximately $1,545,259 in proceeds. The individual trades reported were:

• 2/25/2026: 4,907 shares at $17.00 — $83,419
• 2/26/2026: 73,610 shares at a weighted average $17.14 — $1,261,793
• 2/27/2026: 11,762 shares at $17.01 — $200,047

These were sales (not purchases) and therefore typically represent liquidity or portfolio management rather than a buy signal.

Key Details

• Transaction type: Open-market sales (Code S). Total sold: 90,279 shares for ~$1,545,259.
• Dates and price notes:
  • 2/25/2026 — sold at $17.00 (single price).
  • 2/26/2026 — weighted average $17.14; actual prices ranged $17.00–$17.01 (footnote F2).
  • 2/27/2026 — weighted average $17.01; related sales ranged $17.00–$17.05 or up to $17.25 in portions per footnotes (F4, F5); weighted averages reported.
• Footnotes of interest:
  • F1: Sales were made under a 10b5-1 trading plan adopted Nov 7, 2025 (pre-set trading plan).
  • F3: Shares are held by the "Saiyed Atiq Raza and Nandini Saraiya 2012 Revocable Trust," for which he serves as trustee.
  • F2/F4/F5: Prices shown are weighted averages; the filer can provide a breakdown of prices on request.
• Shares owned after the transactions: Not specified in the provided Form 4 excerpt.
• Filing timeliness: Form 4 was filed Feb 27, 2026; transactions occurred Feb 25–27, 2026. The filing date appears within the typical two-business-day reporting window and is not marked as late.

Context
Sales executed under a 10b5-1 plan are pre-arranged and are generally intended to avoid trading on inside information; they are common for insiders seeking planned liquidity. These are outright sales (not option exercises or gifts) and do not by themselves indicate management’s view of the company’s prospects.